These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 25956892)

  • 61. Nothing to see here.
    Nat Biotechnol; 2008 May; 26(5):476. PubMed ID: 18464755
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Should journals publish industry-funded bioethics articles?
    Elliott C
    Lancet; 2005 Jul 30-Aug 5; 366(9483):422-4. PubMed ID: 16054943
    [No Abstract]   [Full Text] [Related]  

  • 63. Reader objects to increasing ads in veterinary publications.
    Marek K
    J Am Vet Med Assoc; 2008 Jul; 233(2):224-5. PubMed ID: 18642410
    [No Abstract]   [Full Text] [Related]  

  • 64. A positive health strategy for the office waiting room.
    Richards JW
    N Y State J Med; 1983 Dec; 83(13):1358-60. PubMed ID: 6582396
    [No Abstract]   [Full Text] [Related]  

  • 65. Publishing: Predatory publishing.
    Bajpai M
    Br Dent J; 2015 Aug; 219(4):147. PubMed ID: 26315163
    [No Abstract]   [Full Text] [Related]  

  • 66. The rules we follow. An updated ethics code for our staff.
    Burda D
    Mod Healthc; 2004 Nov; 34(44):20. PubMed ID: 15554342
    [No Abstract]   [Full Text] [Related]  

  • 67. "Precious baby".
    Cromer MA
    N Y State J Med; 1983 Dec; 83(13):1292-3. PubMed ID: 6582375
    [No Abstract]   [Full Text] [Related]  

  • 68. More on ads in veterinary publications.
    Colley P
    J Am Vet Med Assoc; 2008 Oct; 233(7):1059; author reply 1059-60. PubMed ID: 18839493
    [No Abstract]   [Full Text] [Related]  

  • 69. Communication and public health: a question of scope or readership?
    White M
    J Public Health Med; 1991 Nov; 13(4):360. PubMed ID: 1764300
    [No Abstract]   [Full Text] [Related]  

  • 70. Whose news is it, anyway?
    Mitka M
    JAMA; 2000 Feb; 283(8):992. PubMed ID: 10697047
    [No Abstract]   [Full Text] [Related]  

  • 71. Drug companies and publishers set out 10 steps to enhance credibility of industry sponsored trials.
    Roehr B
    BMJ; 2012 May; 344():e3767. PubMed ID: 22641830
    [No Abstract]   [Full Text] [Related]  

  • 72. [Ethics in publishing medical papers].
    Strâmbu I
    Pneumologia; 2012; 61(2):74-7. PubMed ID: 22783595
    [No Abstract]   [Full Text] [Related]  

  • 73. The many ways of marketing artificial baby milk.
    Auerbach KG
    J Hum Lact; 1992 Jun; 8(2):61-2. PubMed ID: 1341879
    [No Abstract]   [Full Text] [Related]  

  • 74. For debate: is the influence of the pharmaceutical industry on prescribing, research and publication in the field of psychogeriatrics excessive?
    Ames D
    Int Psychogeriatr; 2007 Dec; 19(6):1003. PubMed ID: 17711607
    [No Abstract]   [Full Text] [Related]  

  • 75. Economics of publishing.
    Hare D
    Can Vet J; 1995 Dec; 36(12):737-8. PubMed ID: 8748441
    [No Abstract]   [Full Text] [Related]  

  • 76. Biomedical industrial sponsorship and its impact on the medical literature.
    Morris PJ
    World J Surg; 2006 Aug; 30(8):1371-3. PubMed ID: 16773249
    [No Abstract]   [Full Text] [Related]  

  • 77. Leopards and ghosts in the temple.
    McKneally MF
    J Thorac Cardiovasc Surg; 2011 Dec; 142(6):1339-40. PubMed ID: 22014716
    [No Abstract]   [Full Text] [Related]  

  • 78. Ghost- and guest-authored pharmaceutical industry-sponsored studies: abuse of academic integrity, the peer review system, and public trust.
    Flaherty DK
    Ann Pharmacother; 2013; 47(7-8):1081-3. PubMed ID: 23585648
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Nothing to declare?
    Nat Methods; 2006 Nov; 3(11):869. PubMed ID: 17124725
    [No Abstract]   [Full Text] [Related]  

  • 80. Replicant I – there's a storm coming: by caveman.
    J Cell Sci; 2014 May; 127(Pt 9):1855-6. PubMed ID: 24910871
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.